Related Experiment Video
Updated: Aug 16, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
C Jonat1, H J Rahmsdorf, K K Park
1Kernforschungszentrum Karlsruhe, Federal Republic of Germany.
Abstract:
Glucocorticoid hormones counteract inflammation and phorbol ester tumor promotion and drastically decrease the expression of several extracellular proteases, including collagenase I. Glucocorticoid hormone inhibits basal and induced transcription of collagenase by interfering with AP-1, the major enhancer factor of the collagenase promoter. The mechanism of interference is novel in that it does not require protein synthesis, it depends on the hormone receptor but not its binding to DNA, it occurs at hormone doses one order of magnitude below those required for gene activation, and it involves down-modulation of the trans-activating function of preexisting unbound and DNA-bound AP-1. Coprecipitation experiments suggest direct AP-1-hormone receptor interaction, which also possibly explains the reverse experiment: overexpression of Fos or Jun inhibits the expression of hormone-dependent genes.
Insights
Glucocorticoid hormones inhibit collagenase I expression by directly interacting with AP-1, a key transcription factor. This novel mechanism down-modulates AP-1 activity without requiring new protein synthesis or DNA binding.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Research
Background:
- Glucocorticoid hormones possess anti-inflammatory and anti-tumor promoting properties.
- These hormones significantly reduce the expression of extracellular proteases, such as collagenase I.
- Collagenase I expression is regulated by transcription factors, including AP-1.
Purpose of the Study:
- To elucidate the novel mechanism by which glucocorticoid hormones inhibit collagenase I gene expression.
- To investigate the role of AP-1 transcription factor in mediating glucocorticoid hormone effects.
- To explore the interaction between hormone receptors and AP-1.
Main Methods:
- Analysis of basal and induced collagenase I transcription.
- Investigation of AP-1 binding and trans-activating function.
- Hormone receptor dependency and DNA binding assays.
- Coprecipitation experiments to detect protein-protein interactions.
- Fos or Jun overexpression studies.
Main Results:
- Glucocorticoid hormones inhibit both basal and induced collagenase I transcription.
- The inhibitory mechanism involves interference with AP-1, independent of protein synthesis or hormone receptor DNA binding.
- Effective inhibition occurs at low hormone doses, down-modulating AP-1's trans-activating function.
- Coprecipitation suggests a direct interaction between AP-1 and the hormone receptor.
- Overexpression of Fos or Jun inhibits hormone-dependent gene expression.
Conclusions:
- Glucocorticoid hormones directly interact with AP-1 to suppress collagenase I expression.
- This interaction is a novel mechanism for gene regulation, distinct from typical hormone-mediated gene activation.
- The findings provide insights into the molecular basis of glucocorticoid action in inflammation and tumor promotion.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...